Specialized Center of Research Program (SCOR) supports interdisciplinary investigator teams pursuing integrated blood cancer research to move laboratory discoveries toward clinical use.
Gilead Sciences funds research and programs addressing social and economic barriers to health equity in cancer care for underserved communities in several countries.
Academic Clinical Trials Program (ACT) supports academic investigators conducting blood cancer trials to test new treatments, expand existing therapy uses, and improve care for unmet medical needs.
Research Grant Program - Children's Leukemia Research Association supports doctors studying leukemia and blood cancers to identify causes, improve treatments, and advance toward a cure.
The Gilead Oncology Grant funds collaborative, evidence-based projects to reduce social and economic barriers to cancer care and advance health equity for underserved populations.